VSMD (Vasamed) ROCE %: -289.40% (As of Sep. 2006)


What is Vasamed ROCE %?

Vasamed VSMD ROCE % is -289.40% as of Sep. 2006.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vasamed's annualized ROCE % for the quarter that ended in Sep. 2006 was -289.40%.

Vasamed  (OTCPK:VSMD) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vasamed ROCE % Related Terms

Vasamed ROCE % Historical Data

* Premium members only.

The historical data trend for Vasamed's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vasamed ROCE % Chart

Vasamed Annual Data
Trend Dec96 Dec97 Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -678.01 0.00 -582.68 0.00 0.00

Vasamed Quarterly Data
Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -560.07 -372.51 -295.39 -220.89 -289.40

Vasamed ROCE % Calculation

Vasamed's annualized ROCE % for the fiscal year that ended in Dec. 2005 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2005 )  (A: Dec. 2004 )(A: Dec. 2005 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2005 )  (A: Dec. 2004 )(A: Dec. 2005 )
=-4.742/( ( (1.021 - 4.716) + (1.6 - 0.986) )/ 2 )
=-4.742/( (-3.695+0.614)/ 2 )
=-4.742/-1.5405
=307.82 %

Vasamed's ROCE % of for the quarter that ended in Sep. 2006 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2006 )  (Q: Jun. 2006 )(Q: Sep. 2006 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2006 )  (Q: Jun. 2006 )(Q: Sep. 2006 )
=-4.94/( ( (3.254 - 1.372) + (3.08 - 1.548) )/ 2 )
=-4.94/( ( 1.882 + 1.532 )/ 2 )
=-4.94/1.707
=-289.40 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2006) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -289.40% mean?
Vasamed (VSMD) has a ROCE % of -289.40% as of Sep. 2006.
Is Vasamed's ROCE % too high?
Vasamed's current ROCE % is -289.40%.
How does Vasamed's ROCE % compare to LENSF and WHSI?
Vasamed's ROCE % of -289.40% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vasamed's current ROCE % is -289.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vasamed stock overvalued right now?
Vasamed (VSMD) has a current ROCE % of -289.40%. The current ROCE % is -289.40%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Vasamed (VSMD), the current ROCE % is -289.40% as of Sep. 2006. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vasamed Business Description

Address 7615 Golden Triangle Drive, Suite A, Eden Prairie, MN, USA, 55344-3733
Vasamed Inc develops, manufactures and markets low-cost, non-invasive peripheral and cardiovascular diagnostic systems for hemodynamic assessment.